To Study the Prescribing Pattern of Drugs in Dengue Patients of a Tertiary Care Hospital: A Prospective and Observational Study

S.M. Biradar¹ , K. Maurya² , A. Naikal³ , S. Sarnadgowd⁴ , Rajesh M. Honnutagi⁵ , Ravi Kattimani⁶ , Shivakumar B.⁷ , V.T. Kallyanappagol⁸

Section:Research Paper, Product Type: Journal-Paper
Vol.7 , Issue.6 , pp.151-155, Dec-2020

Online published on Dec 31, 2020

Copyright © S.M. Biradar, K. Maurya, A. Naikal, S. Sarnadgowd, Rajesh M. Honnutagi, Ravi Kattimani, Shivakumar B., V.T. Kallyanappagol . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
Dengue fever (DF) is an acute febrile illness which is transmitted by mosquito bite. Annually 5 lakhs of patients are hospitalized and more than 20,000 deaths are reported worldwide. Till today there is no specific therapy available for DF, therefore it is very essential to study the prescribing pattern of drugs among dengue patients in order to make the pharmacotherapy streamline and reduce the mortality rate. A Prospective observational prescription pattern study was conducted for a period of six months in a tertiary care hospital. The sample size of the study was 100 from medicine and pediatric departments and relevant information were extracted from respective files and selected patients. A total of 661 drugs were prescribed among selected dengue patients, in whom 145 were anti-invectives, out of them 143 drugs were antibiotics, Cefixime contributes 35% and followed by Doxycyclin 25.8% and remaining 516 drugs were as supportive therapy. DF was more prevalent in males and prominent in age group of 11-20 years. As concern with the laboratory diagnosis, it was seen that the NS1positive were 97% and IgM positive were 3%, indicates the most of the patients were brought to the hospital in time, because the NS1 is detected early stage of dengue infection. The hematological values (SBP, DBP, PCV, PLT & TC) were in the optimal range indicating the treatment was started abruptly and prescription was most appropriate to the medical condition of patients.

Key-Words / Index Term :
Prescribing pattern; Dengue fever (DF); Anti-infective; Supportive therapy

References :
[1]. O.G. Indusree, J S. Chandana, V S. Ajitha, Larvicidal Efficacies of Certain Plant Extracts against Fourth Instar Larvae of Aedes albopictus Skuse. Int J of Sci Res Biol Sci, Vol. 6, Issue 1, pp. 220-225, 2020.
[2]. Shaktibala, Mirza Atif Beg, Bawa Shalu, Mohammad Anjoom, Shubhash Vishal. Study on drug prescribing pattern in dengue patients in tertiary care hospital. J of Drug Del and Ther , Vol. 5, issue 2, pp.73-76, 2015.
[3]. Gupta sakshee, Vyas Nitya, Bithu Rameshwari, Yadav Rajeev, Sharma Babita. Seropositivity and seasonal trend of dengue cases in Jaipur, western India 2010–2016. Int Mult J Heal, Vol. 6, issue 3, pp. 152-57, 2017.
[4]. James M Heilman, Jacob De Wolff, Graham M Beards, Brian J Basden. Dengue Fever: a Wikipedia clinical review. Open Med, Vol. 8, issue 4, pp. 105-15, 2014.
[5]. Das Sushmita, Sarfraz Asim, Jaiswal Nitesh, Das Pradeep. Impediments of reporting dengue cases in India. J Infect Public Health, Vol. 10, issue 5, pp. 494-98, 2017.
[6]. Michael B. Nathan, Renu Dayal-Drager, Maria Guzman. Epidemiology, Burden of diseases and Transmission. A joint publication of the WHO and TDR. Dengue: guidelines for diagnosis, treatment, prevention and control, New edn Geneva: World Health Organisation;. pp. 3-21, 2009.
[7]. AK Hafeez, MA Akheel, A Ashfaque, NK Meera. Prescribing Pattern for the Treatment of Dengue in a Tertiary Care Hospital, Bangalore. Sch Pharm Sci , pp. 01-03, 2016.
[8]. Pawar Rohit, Patravale Vandana. Dengue diagnosis: challenges and opportunities. Immunochem Immunopathol, Vol. 1, issue 1, pp. 1-10, 2015.
[9]. Byron E. E. Martina, Penelope Koraka, Albert D. M. E. Osterhaus. Dengue Virus Pathogenesis: An Integrated View. ASM Microbe,Vol. 22, issue 4, pp. 564–81, 2009.
[10]. Uton Muchtar Rafei. Manifestation of Dengue Infection. Guidelines for Treatment of Dengue Fever/Dengue Hemorrhagic Fever in Small Hospitals. New Delhi: World Health Organisation; pp. 1-28, 1999.
[11]. Robert V Gibbons, David W Vaughn. Dengue: an escalating problem. BMJ, Vol. 324, issue 7353, pp. 1563–1566, 2002.

[12]. Duane J. Gubler. Dengue and Dengue Hemorrhagic Fever. Clin Microbiol Rev, Vol. 11, issue 3, pp. 480–96, 1998.

[13]. Parvathy Krishna Pillai Sathidevi. Dengue epidemic- knowledge gaps and its mending in Kerala, India. Int J Mosq Res, Vol. 4, issue 1, pp. 19-2, 2017.

[14]. Siripen Kalayanarooj. Clinical Manifestations and Management of Dengue/DHF/DSS. Trop Med Health, Vol. 39, issue 4, pp. 83-87, 2011.
[15]. Ravindra Ruberu, Kamani Wanigasuriya, Sudath Peiris. Discharge Criteria. Pradeep Wijayagoonawardana. Guidelines on Management of Dengue Fever and Dengue Haemorrhagic Fever In Adults. Colombo: Ministry of Health - Sri Lanka National Guidelines in Collaboration with the Ceylon College of Physicians;. pp. 1-34, 2010.
[16]. U.S. Department Of Health And Human Services. Centers for Disease Control and Prevention. Dengue and Dengue Hemorrhagic Fever. pp. 1-4, 2009.
[17]. Krishna Murthy Sirigadha, Md. Khaleel. A Study on the Laboratory Profiles in Dengue Viral Infection. Int.J.Curr.Microbiol App Sci,Vol. 6, issue 1, pp. 387-95, 2017.
[18]. Amrita Ojha, Dipika Nandi, Harish Batra, Rashi Singhal, Gowtham K. Annarapu, Sankar Bhattacharyya, et al. Platelet activation determines the severity of thrombocytopenia in dengue infection. Sci Rep , Vol. 7, pp. 41697, 2017.
[19]. Deepti Pruthvi, Shashikala P, Vasavi Shenoy. Evaluation of Platelet Count in Dengue Fever along with Seasonal Variation of Dengue Infection. J Blo Dis Transfus , Vol. 3, issue 4, pp. 1-4, 2012.
[20]. Hari Kishan Jayanthi, Sai Krishna Tulasi. Correlation study between platelet count, leukocyte count, non hemorrhagic complications, and duration of hospital stay in dengue fever with thrombocytopenia. J Family Med Prim Care, Vol. 5, issue 1, pp. 120-23, 2016.
[21]. Rani Usha, Kamat G. Sangita, V. H. Varun, Aithal Sathisha, Patil N. Umakant. Prescribing Patterns in Dengue Fever in Paediatric Patients in A Tertiary Care Hospital:A Retrospective Cross Sectional Study. Int J Pharm Sci Rev Res, Vol. 24, issue 2, pp. 112-18, 2014.